Overview Dividends

(SLQT) Selectquote - Ratings and Ratios

Exchange: NYSE • Country: United States • Currency: USD • Type: Common Stock • ISIN: US8163073005

Medicare, Medicare, Life, Pharmacy, Insurance

SLQT EPS (Earnings per Share)

EPS Growth (3Y CAGR): -12.92%
EPS Trend (3Y Correlation): 7.6%

SLQT Revenue

Revenue Growth (3Y CAGR): 31.51%
Revenue Trend (3Y Correlation): 66.5%

Description: SLQT Selectquote October 25, 2025

SelectQuote, Inc. (NYSE: SLQT) runs a technology-driven, direct-to-consumer platform that sells a range of insurance and health-care services across three segments: Senior (Medicare Advantage, Medicare Supplement, Part D and related ancillary products), Healthcare Services (pharmacy and chronic-condition management solutions such as SelectRx, Healthcare Select, Home™ and SelectPatient Management), and Life (term life, final-expense and other ancillary policies). The firm also generates leads for non-commercial auto, homeowners, property and casualty lines.

Key operating metrics from the most recent fiscal year show revenue of roughly $1.1 billion, with the Senior segment contributing about 55 % of total sales and delivering a combined ratio near 92 %, indicating modest underwriting profitability. The business benefits from macro trends such as the aging U.S. population-projected to reach 21 % of residents by 2030-and the continued growth of Medicare enrollment, which drives demand for both core and ancillary senior products. Additionally, the shift toward digital acquisition channels has helped SelectQuote maintain a customer acquisition cost (CAC) that is roughly 20 % lower than the industry average for comparable insurers.

For a deeper quantitative assessment, you may find ValueRay’s analytics useful for modeling SLQT’s earnings sensitivity to Medicare enrollment trends and digital acquisition dynamics.

SLQT Stock Overview

Market Cap in USD	366m
Sub-Industry	Property & Casualty Insurance
IPO / Inception	2020-05-21

SLQT Stock Ratings

Growth Rating	1.69%
Fundamental	61.6%
Dividend Rating	-
Return 12m vs S&P 500	-16.2%
Analyst Rating	4.0 of 5

SLQT Dividends

Currently no dividends paid

SLQT Growth Ratios

Growth Correlation 3m	-9.2%
Growth Correlation 12m	-74.3%
Growth Correlation 5y	-42.4%
CAGR 5y	44.93%
CAGR/Max DD 3y (Calmar Ratio)	0.63
CAGR/Mean DD 3y (Pain Ratio)	1.17
Sharpe Ratio 12m	-1.37
Alpha	-22.85
Beta	1.291
Volatility	75.12%
Current Volume	862.4k
Average Volume 20d	856.6k
Stop Loss	1.9 (-6.9%)
Signal	-0.52

Piotroski VR‑10 (Strict, 0-10) 4.5

Net Income (47.6m TTM) > 0 and > 6% of Revenue (6% = 91.6m TTM)

FCFTA -0.01 (>2.0%) and ΔFCFTA -1.17pp (YES ≥ +1.0pp, WARN ≥ +0.5pp)

NWC/Revenue 8.39% (prev 11.98%; Δ -3.59pp) (YES ≤20% & Δ≤-1pp; WARN ≤25% & Δ≤0 oder ≤40% & Δ≤-3pp)

CFO/TA -0.01 (>3.0%) and CFO -11.7m <= Net Income 47.6m (YES >=105%, WARN >=100%)

Net Debt (63.6m) to EBITDA (109.4m) ratio: 0.58 <= 3.0 (WARN <= 3.5)

Current Ratio 1.60 (target 1.5–3.0; WARN 1.2–<1.5 or >3.0–5.0; CFO/TA gate active)

Outstanding Shares last Quarter (184.2m) change vs 12m ago 9.31% (target <= -2.0% for YES)

Gross Margin 61.30% (prev 51.60%; Δ 9.70pp) >=18% & Δ>=+0.5pp (WARN >=15% & Δ>=0)

Asset Turnover 114.0% (prev 110.7%; Δ 3.25pp) >=50% & Δ>=+2pp (WARN >=35% & Δ>=0)

Interest Coverage Ratio 1.14 (EBITDA TTM 109.4m / Interest Expense TTM 78.1m) >= 6 (WARN >= 3)

Altman Z'' 0.27

(A) 0.09 = (Total Current Assets 341.0m - Total Current Liabilities 212.9m) / Total Assets 1.49b

(B) -0.15 = Retained Earnings (Balance) -222.2m / Total Assets 1.49b

(D) -0.24 = Book Value of Equity -220.5m / Total Liabilities 909.8m

Total Rating: 0.27 = (6.56 * A) + (3.26 * B) + (6.72 * C) + (1.05 * D)

ValueRay F-Score (Strict, 0-100) 61.55

1. Piotroski 4.50pt = -0.50

2. FCF Yield -3.23% = -1.61

3. FCF Margin -0.91% = -0.34

4. Debt/Equity 0.17 = 2.49

5. Debt/Ebitda 0.58 = 2.24

6. ROIC - WACC (= 2.39)% = 2.99

7. RoE 11.01% = 0.92

8. Rev. Trend 66.49% = 4.99

9. EPS Trend 7.57% = 0.38

What is the price of SLQT shares?

As of November 06, 2025, the stock is trading at USD 2.04 with a total of 862,429 shares traded.
Over the past week, the price has changed by -3.77%, over one month by -1.45%, over three months by +15.91% and over the past year by +0.49%.

Is Selectquote a good stock to buy?

Neither. Based on ValueRay´s Fundamental Analyses, Selectquote is currently (November 2025) neither a good nor a bad stock to buy. It has a ValueRay Fundamental Rating of 61.55 and therefor a neutral outlook according to the companies health.
Based on momentum, paid dividends and discounted-cash-flow analyses, the fair value of SLQT is around 1.51 USD . This means that SLQT is currently overvalued and has a potential downside of -25.98%.

Is SLQT a buy, sell or hold?

Selectquote has received a consensus analysts rating of 4.00. Therefore, it is recommended to buy SLQT.

Strong Buy: 2
Buy: 0
Hold: 2
Sell: 0
Strong Sell: 0

What are the forecasts/targets for the SLQT price?

Issuer	Target	Up/Down from current
Wallstreet Target Price	5.3	157.4%
Analysts Target Price	5.3	157.4%
ValueRay Target Price	1.7	-15.2%

SLQT Fundamental Data Overview November 04, 2025

Market Cap USD = 365.8m (365.8m USD * 1.0 USD.USD)
P/E Trailing = 208.0
P/E Forward = 66.6667
P/S = 0.2396
P/B = 1.0188
Beta = 1.291
Revenue TTM = 1.53b USD
EBIT TTM = 88.9m USD
EBITDA TTM = 109.4m USD
Long Term Debt = 316.6m USD (from longTermDebt, last quarter)
Short Term Debt = 78.2m USD (from shortTermDebt, last quarter)
Debt = 99.3m USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 63.6m USD (from netDebt column, last quarter)
Enterprise Value = 429.4m USD (365.8m + Debt 99.3m - CCE 35.7m)
Interest Coverage Ratio = 1.14 (Ebit TTM 88.9m / Interest Expense TTM 78.1m)
FCF Yield = -3.23% (FCF TTM -13.9m / Enterprise Value 429.4m)
FCF Margin = -0.91% (FCF TTM -13.9m / Revenue TTM 1.53b)
Net Margin = 3.12% (Net Income TTM 47.6m / Revenue TTM 1.53b)
Gross Margin = 61.30% ((Revenue TTM 1.53b - Cost of Revenue TTM 590.9m) / Revenue TTM)
Gross Margin QoQ = 82.95% (prev 80.54%)
Tobins Q-Ratio = 0.29 (Enterprise Value 429.4m / Total Assets 1.49b)
Interest Expense / Debt = 11.00% (Interest Expense 10.9m / Debt 99.3m)
Taxrate = -37.27% (negative due to tax credits) (-3.49m / 9.38m)
NOPAT = 122.0m (EBIT 88.9m * (1 - -37.27%)) [negative tax rate / tax credits]
Current Ratio = 1.60 (Total Current Assets 341.0m / Total Current Liabilities 212.9m)
Debt / Equity = 0.17 (Debt 99.3m / totalStockholderEquity, last quarter 575.5m)
Debt / EBITDA = 0.58 (Net Debt 63.6m / EBITDA 109.4m)
Debt / FCF = -4.59 (negative FCF - burning cash) (Net Debt 63.6m / FCF TTM -13.9m)
Total Stockholder Equity = 432.2m (last 4 quarters mean from totalStockholderEquity)
RoA = 3.20% (Net Income 47.6m / Total Assets 1.49b)
RoE = 11.01% (Net Income TTM 47.6m / Total Stockholder Equity 432.2m)
RoCE = 11.87% (EBIT 88.9m / Capital Employed (Equity 432.2m + L.T.Debt 316.6m))
RoIC = 14.08% (NOPAT 122.0m / Invested Capital 866.4m)
WACC = 11.69% (E(365.8m)/V(465.2m) * Re(10.77%) + D(99.3m)/V(465.2m) * Rd(11.00%) * (1-Tc(-0.37)))
Discount Rate = 10.77% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: 100.0 | Cagr: 4.17%
Fair Price DCF = unknown (Cash Flow -13.9m)
EPS Correlation: 7.57 | EPS CAGR: -12.92% | SUE: 2.58 | # QB: 2
Revenue Correlation: 66.49 | Revenue CAGR: 31.51% | SUE: 0.77 | # QB: 0

Additional Sources for SLQT Stock

News: Wall Street Journal | Benzinga | Yahoo Finance
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle